Recommended

New webinar: Overcoming critical challenges in AI-driven drug discovery
Watch on demand: Rapid cell-based profiling of multi-target anti-obesity drugs Watch here!
Download now: Unlock the power of stem cell therapy and discover the potential for new therapies for primary open-angle glaucoma
Brand new Beyond the Lab report on antibodies… Download NOW!
article

Expert view: Analytical power tool opens upstream bioprocessing bottlenecks for better antibody screening

The Octet® systems provide broad applications in high throughput to help bispecific and multi-specific antibody discovery.

Bio-layer interferometry (BLI) has shown practicality and effectiveness in monitoring antibody-antigen interactions, as binding events are monitored directly in real-time and label-free. The use of this microfluidic-free technology has increased rapidly in the past decade and this trend is predicted to continue as the technology continues to gain widespread acceptance and diversifies its application base, for example, with the characterisation of bispecific antibodies.

    To read this expert view in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of FortéBio

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.